These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20625242)

  • 1. MeCP2 mutant protein is expressed in astrocytes as well as in neurons and localizes in the nucleus.
    Kifayathullah LA; Arunachalam JP; Bodda C; Agbemenyah HY; Laccone FA; Mannan AU
    Cytogenet Genome Res; 2010; 129(4):290-7. PubMed ID: 20625242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2.
    Tsujimura K; Abematsu M; Kohyama J; Namihira M; Nakashima K
    Exp Neurol; 2009 Sep; 219(1):104-11. PubMed ID: 19427855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.
    Belichenko NP; Belichenko PV; Mobley WC
    Neurobiol Dis; 2009 Apr; 34(1):71-7. PubMed ID: 19167498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A segment of the Mecp2 promoter is sufficient to drive expression in neurons.
    Adachi M; Keefer EW; Jones FS
    Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rett syndrome: from the gene to the disease.
    Matijevic T; Knezevic J; Slavica M; Pavelic J
    Eur Neurol; 2009; 61(1):3-10. PubMed ID: 18948693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered microtubule dynamics in Mecp2-deficient astrocytes.
    Nectoux J; Florian C; Delepine C; Bahi-Buisson N; Khelfaoui M; Reibel S; Chelly J; Bienvenu T
    J Neurosci Res; 2012 May; 90(5):990-8. PubMed ID: 22252744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
    Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
    Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype.
    Hoffbuhr KC; Moses LM; Jerdonek MA; Naidu S; Hoffman EP
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):99-105. PubMed ID: 12112735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and distribution of MECP2 mutations in 424 Rett syndrome patients: a molecular update.
    Philippe C; Villard L; De Roux N; Raynaud M; Bonnefond JP; Pasquier L; Lesca G; Mancini J; Jonveaux P; Moncla A; Chelly J; Bienvenu T
    Eur J Med Genet; 2006; 49(1):9-18. PubMed ID: 16473305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cis-regulatory elements for MECP2 expression.
    Liu J; Francke U
    Hum Mol Genet; 2006 Jun; 15(11):1769-82. PubMed ID: 16613900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome.
    Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS
    Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions.
    Kishi N; Macklis JD
    Mol Cell Neurosci; 2004 Nov; 27(3):306-21. PubMed ID: 15519245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.
    Ben-Zeev B; Aharoni R; Nissenkorn A; Arnon R
    Med Hypotheses; 2011 Feb; 76(2):190-3. PubMed ID: 20951500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of methyl-CpG binding protein 2 (MeCP2) regulates the intracellular localization during neuronal cell differentiation.
    Miyake K; Nagai K
    Neurochem Int; 2007 Jan; 50(1):264-70. PubMed ID: 17052801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome.
    Huppke P; Held M; Hanefeld F; Engel W; Laccone F
    Neuropediatrics; 2002 Apr; 33(2):63-8. PubMed ID: 12075485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyopherin α 3 and karyopherin α 4 proteins mediate the nuclear import of methyl-CpG binding protein 2.
    Baker SA; Lombardi LM; Zoghbi HY
    J Biol Chem; 2015 Sep; 290(37):22485-93. PubMed ID: 26245896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.